Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, potentially for the purchase of HYPE tokens

ChainCatcher news, Hyperliquid Strategies Inc. submitted an S-1 registration statement to the U.S. Securities and Exchange Commission, intending to issue up to 160 million shares of common stock and raise up to $1 billion through a committed equity financing agreement (Facility) signed with Chardan Capital Markets after completing a dual merger transaction with Sonnet BioTherapeutics Holdings and Rorschach I LLC. The raised funds will be used for general corporate purposes, including possibly purchasing HYPE Token.